WordNet

suggestive of a thyroid disorder; "thyroid personality"
of or relating to the thyroid gland; "thyroid deficiency"; "thyroidal uptake" (同)thyroidal
any of various organs that synthesize substances needed by the body and release it through ducts or directly into the bloodstream (同)secretory organ, secretor, secreter
thoroughly dried out; "old boxes of desiccated Cuban cigars"; "dried-out boards beginning to split" (同)dried-out

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 外因性甲状腺機能亢進症 exogenous hyperthyroidism
2. 成人の原発性甲状腺機能低下症の治療 treatment of primary hypothyroidism in adults
3. 甲状腺結節および良性甲状腺腫に対する甲状腺ホルモン抑制療法 thyroid hormone suppressive therapy for thyroid nodules and benign goiter
4. 唾石症 salivary gland stones
5. 唾液腺腫瘍：疫学、診断、評価、および病期分類 salivary gland tumors epidemiology diagnosis evaluation and staging

Calil-Silveira J1, Serrano-Nascimento C1, Kopp P2, Nunes MT3.
American journal of physiology. Cell physiology.Am J Physiol Cell Physiol.2016 Jan 20:ajpcell.00210.2015. doi: 10.1152/ajpcell.00210.2015. [Epub ahead of print]
Adequate iodide supply and metabolism are essential for thyroid hormones synthesis. In thyrocytes, iodide uptake is mediated by the sodium-iodide symporter (NIS), but several proteins appear to be involved in iodide efflux. Previous studies demonstrated that pendrin is able to mediate apical efflux
PMID 26791486

Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.

Diniz GP1, Senger N1, Carneiro-Ramos MS2, Santos RA3, Barreto-Chaves ML4.
Therapeutic advances in cardiovascular disease.Ther Adv Cardiovasc Dis.2015 Dec 28. pii: 1753944715623228. [Epub ahead of print]
OBJECTIVES: Thyroid hormone (TH) promotes marked effects on the cardiovascular system, including the development of cardiac hypertrophy. Some studies have demonstrated that the renin-angiotensin system (RAS) is a key mediator of the cardiac growth in response to elevated TH levels. Although some of
PMID 26715125

Sorafenib for the treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.

Castroneves LA1, Negrao MV2, Freitas RM3, Papadia C4, Lima Junior JV5, Fukushima J6, Simao EF7, Kulcsar MA8, Tavares M9, Jorge AA10, Castro G Jr11, Hoff PM12, Hoff AO13.
Thyroid : official journal of the American Thyroid Association.Thyroid.2015 Dec 23. [Epub ahead of print]
BACKGROUND: Treatment of advanced medullary thyroid carcinoma (MTC) was recently improved with the approval of vandetanib and cabozantinib. However, there is still a need to explore sequential therapy with more than one tyrosine kinase inhibitor (TKI) and to explore alternative therapies when vandet
PMID 26701095